These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6348227)

  • 1. Single-dose amikacin treatment of first childhood E. coli lower urinary tract infections.
    Wallen L; Zeller WP; Goessler M; Connor E; Yogev R
    J Pediatr; 1983 Aug; 103(2):316-9. PubMed ID: 6348227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amikacin in urinary tract infections with so-called problem pathogens].
    Hofstetter A; Staehler G
    Fortschr Med; 1976 Aug; 94(24):1305-8. PubMed ID: 786834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-course aminoglycoside therapy in patients with spinal cord injury. Standard dose versus low dose.
    Sapico FL; Lindquist LB; Montgomerie JZ; Jimenez EM; Morrow JW
    Urology; 1980 May; 15(5):457-60. PubMed ID: 6763394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative efficacy of cephalexin and sulfisoxazole in acute urinary tract infection in children.
    Russo RM; Gururaj VJ; Laude TA; Rajkumar SV; Allen JE
    Clin Pediatr (Phila); 1977 Jan; 16(1):83-4, 89-91. PubMed ID: 318609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of single-dose and three-day trimethoprim-sulfadiazine and amikacin treatment of induced Escherichia coli urinary tract infections in dogs.
    Rogers KS; Lees GE; Simpson RB
    Am J Vet Res; 1988 Mar; 49(3):345-9. PubMed ID: 3282460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin in gram-negative paediatric infections.
    Trujillo H; Manotas R; Ramirez JI; Uribe A; Agudelo N; Zapata CT; Zuluaga AI; de Vidal EL
    J Int Med Res; 1978; 6(4):257-65. PubMed ID: 357227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amikacin pharmacokinetics in the therapy of childhood urinary tract infection.
    Khan AJ; Evans HE; Jhaveri R; Chang CT; Hochstein L
    Pediatrics; 1976 Dec; 58(6):873-6. PubMed ID: 995517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect and pharmacokinetics of netilmicin given as bolus intramuscular administration: an open comparative trial versus amikacin and fosfomycin in elderly patients affected by urinary tract infections.
    Caramalli S; Amprimo MC; Cavalli G; Mantelli M; Pollastrelli E; Raiteri F; Varese LA; Franchino L
    Int J Clin Pharmacol Res; 1991; 11(2):55-65. PubMed ID: 1879990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
    Feld R; Valdivieso M; Bodey GP; Rodriguez V
    J Infect Dis; 1977 Jan; 135(1):61-6. PubMed ID: 401853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli infections in knee joints. The pharmacological and antibacterial effects of intramuscular antibiotics.
    Schurman DJ; Kajiyama G; Nagel DA
    J Bone Joint Surg Am; 1980; 62(4):620-7. PubMed ID: 6991503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].
    Federspil P; Schindler K; Weich C; Tiesler E; Schätzle W; Ziegler M
    Infection; 1979; 7(2):81-7. PubMed ID: 374277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Ipekci T; Seyman D; Berk H; Celik O
    J Infect Chemother; 2014 Dec; 20(12):762-7. PubMed ID: 25179392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.
    Wu TH; Huang FL; Fu LS; Chou CM; Chien YL; Huang CM; Lin CF; Chen PY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):717-722. PubMed ID: 25442872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of complicated urinary tract infections with amikacin: comparison of low and high dosage.
    Harrison LH
    Urology; 1977 Aug; 10(2):110-3. PubMed ID: 331627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
    Wirt TC; McGee ZA; Oldfield EH; Meacham WF
    J Neurosurg; 1979 Jan; 50(1):95-9. PubMed ID: 363982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report on a swift shift in uropathogens from Shigella flexneri to Escherichia coli: a thin line between bacterial persistence and reinfection.
    Tufon KA; Fokam DPY; Kouanou YS; Meriki HD
    Ann Clin Microbiol Antimicrob; 2020 Jul; 19(1):31. PubMed ID: 32727466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Cho SY; Choi SM; Park SH; Lee DG; Choi JH; Yoo JH
    Korean J Intern Med; 2016 Jan; 31(1):156-61. PubMed ID: 26767869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amikacin and gentamicin: a controlled comparison (author's transl)].
    Höffler D
    Dtsch Med Wochenschr; 1978 Dec; 103(52):2071-5. PubMed ID: 365487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of amikacin for treatment of urinary tract infections in patients with reduced renal function.
    Höffler D; Koeppe P; Demers HG
    J Infect Dis; 1976 Nov; 134 SUPPL():S369-73. PubMed ID: 993628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.